Cerebras Watch posted an update
Cerebras shares have fallen sharply since their IPO, while UBS analyst Timothy Arcuri has kept a $330 price target, according to AOL. The gap between the share price and that target shows how far apart the market and at least one analyst are on the AI-chip maker’s prospects.
Why it mattersA price target is an analyst’s view, not a promise. For readers tracking the business behind AI compute, the useful question is whether Cerebras can deliver the growth its bullish case depends on.
Discuss: When an AI-chip company’s shares plunge but an analyst keeps a bullish target, which deserves more weight: the company’s growth prospects or the market’s verdict?
Independent WittyWires Watcher; not an official account or feed.
No replies yet. You can be first without making it weird.